Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124127693 | 12412769 | 3 | F | 20160705 | 20160527 | 20160729 | PER | US-PFIZER INC-2016270868 | PFIZER | 75.00 | YR | F | Y | 64.86000 | KG | 20160729 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124127693 | 12412769 | 1 | PS | CELEBREX | CELECOXIB | 1 | 200 MG, 1X/DAY | U | 20998 | 200 | MG | CAPSULE, HARD | QD | ||||||
| 124127693 | 12412769 | 2 | SS | CELEBREX | CELECOXIB | 1 | U | 20998 | CAPSULE, HARD | ||||||||||
| 124127693 | 12412769 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 500 MG, 2X/DAY | 0 | 500 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124127693 | 12412769 | 1 | Rheumatoid arthritis |
| 124127693 | 12412769 | 2 | Psoriatic arthropathy |
| 124127693 | 12412769 | 3 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124127693 | 12412769 | Drug ineffective | |
| 124127693 | 12412769 | Gait disturbance | |
| 124127693 | 12412769 | Influenza | |
| 124127693 | 12412769 | Malaise | |
| 124127693 | 12412769 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |